BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21492078)

  • 1. Genes associated with epithelial-mesenchymal transition: possible therapeutic targets in ductal pancreatic adenocarcinoma?
    Hotz HG; Hotz B; Buhr HJ
    Anticancer Agents Med Chem; 2011 Jun; 11(5):448-54. PubMed ID: 21492078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma.
    Satoh K; Hamada S; Shimosegawa T
    J Gastroenterol; 2015 Feb; 50(2):140-6. PubMed ID: 25216997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma.
    Träger MM; Dhayat SA
    Int J Cancer; 2017 Jul; 141(1):24-32. PubMed ID: 28133736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
    Sato R; Semba T; Saya H; Arima Y
    Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
    Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
    Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
    Garg M
    Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
    Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
    Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer stem cells: emerging target for designing novel therapy.
    Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
    Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
    Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
    Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition.
    Zhao X; Lu Y; Nie Y; Fan D
    Curr Cancer Drug Targets; 2013 Nov; 13(9):935-44. PubMed ID: 24168189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
    Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
    Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer.
    Ishiwata T
    Pathol Int; 2016 Nov; 66(11):601-608. PubMed ID: 27510923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication.
    Yang L; Shang Z; Long S; Wang N; Shan G; Zhang R
    Exp Cell Res; 2018 Sep; 370(2):190-197. PubMed ID: 30075173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
    Wang S; Huang S; Sun YL
    Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.
    Nantajit D; Lin D; Li JJ
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1697-713. PubMed ID: 25270087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer stem cells: new insight into a stubborn disease.
    Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
    Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.